Astera Labs (NASDAQ:ALAB) Trading Up 11.5% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price was up 11.5% during trading on Friday . The stock traded as high as $160.23 and last traded at $162.6340. Approximately 2,773,613 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 5,365,280 shares. The stock had previously closed at $145.88.

Analyst Ratings Changes

A number of research firms have issued reports on ALAB. Stifel Nicolaus raised their target price on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Citigroup restated an “outperform” rating on shares of Astera Labs in a research note on Tuesday, December 9th. BNP Paribas Exane assumed coverage on shares of Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating and a $225.00 target price for the company. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Finally, Bank of America initiated coverage on shares of Astera Labs in a research note on Friday, October 3rd. They set a “neutral” rating and a $230.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $188.17.

Astera Labs Stock Up 12.9%

The company’s 50-day moving average price is $160.56 and its 200-day moving average price is $154.57. The firm has a market cap of $27.81 billion, a price-to-earnings ratio of 148.36, a price-to-earnings-growth ratio of 2.61 and a beta of 1.51.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same period in the previous year, the business earned $0.23 earnings per share. The firm’s revenue for the quarter was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. This trade represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the transaction, the chief financial officer directly owned 192,297 shares in the company, valued at approximately $27,823,452.93. This trade represents a 5.61% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 586,936 shares of company stock worth $89,331,140. 12.50% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the stock. Clearstead Advisors LLC boosted its stake in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after buying an additional 76 shares during the period. Great Valley Advisor Group Inc. raised its stake in shares of Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after acquiring an additional 90 shares during the period. Straight Path Wealth Management lifted its holdings in shares of Astera Labs by 1.5% in the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after acquiring an additional 100 shares during the last quarter. Rye Brook Capital LLC boosted its position in shares of Astera Labs by 1.1% during the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares during the period. Finally, Assetmark Inc. boosted its position in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.